Blood Glial Fibrillary Acidic Protein in MRI ‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder
European Journal of Neurology · 2026
DOI: 10.1111/ene.70784 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2026. Verfasst von Su-Hyun Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea. Hauptthemen laut MEDLINE: Neuromyelitis Optica, Glial Fibrillary Acidic Protein. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Center.
Abstract (Originalsprache)
Objectives
Magnetic resonance imaging (MRI) is widely used to support relapse diagnosis in neuromyelitis optica spectrum disorder (NMOSD), yet some patients present with attack‐like symptoms without corresponding lesions. We assessed serum glial fibrillary acidic protein (sGFAP) levels in MRI‐negative attack‐like episodes.
Methods
We retrospectively analyzed aquaporin‐4‐IgG–positive NMOSD patients presenting with relapse‐like symptoms but without corresponding new MRI lesions. sGFAP was measured from stored serum collected at presentation and converted to demographic‐adjusted z ‐scores. A predefined attack‐associated threshold ( z ‐score ≥ 3.0) was based on prior work.
Results
We identified 39 MRI‐negative attack‐like episodes from 34 patients. Most episodes were clinically mild or subjective, with objective worsening observed in 23%. Eight episodes (21%) showed elevated sGFAP levels (median z ‐score 4.56 [1748 pg/mL]). Compared with episodes without elevated sGFAP, these episodes occurred closer to prior attacks (8 vs. 33 months) and more frequently met objective worsening criteria (50% vs. 16%). In all episodes with elevated sGFAP, remission samples showed normalization below the threshold.
Discussion
Marked sGFAP elevation in a subset of MRI‐negative episodes suggests that some events may represent relapse not captured by conventional imaging. sGFAP may serve as a complementary biomarker to support attack identification when clinical and MRI findings are inconclusive.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea.
ORCID-Profile: Su-Hyun Kim, Jieun Chung, Rosah May Palermo Payumo, Ho Jin Kim
Förderung
- National Cancer Center
Zitieren
APA
Kim, S. H., Chung, J., Payumo, R. M. P., Hyun, J. W., & Kim, H. J. (2026). Blood Glial Fibrillary Acidic Protein in MRI ‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder. European Journal of Neurology. https://doi.org/10.1111/ene.70784
Vancouver
Kim SH, Chung J, Payumo RMP, Hyun JW, Kim HJ. Blood Glial Fibrillary Acidic Protein in MRI ‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder. European Journal of Neurology. 2026. doi:10.1111/ene.70784
BibTeX
@article{Kim2026,
author = {Kim, Su-Hyun and Chung, Jieun and Payumo, Rosah May Palermo and Hyun, Jae-Won and Kim, Ho Jin},
title = {Blood Glial Fibrillary Acidic Protein in MRI ‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder},
journal = {European Journal of Neurology},
year = {2026},
doi = {10.1111/ene.70784}
}
EUVIMED